For example, polymeric nanoparticle-based treatments, engineered to target the epidermal growth factor receptor (EGFR), which is often overexpressed in NSCLC, deliver therapeutic agents directly to cancer cells, enhancing efficacy while minimizing side effects (Crintea et al., 2023). Here, EGFR is linked to non-small cell lung carcinoma.